Engineering PEG10 assembled endogenous virus-like particles with genetically encoded neoantigen peptides for cancer vaccination
Ruijing Tang, Luobin Guo, Tingyu Wei, Tingting Chen, Huan Yang, Honghao Ye, Fangzhou Lin, Yongyi Zeng, Haijun Yu, Zhixiong Cai, Xiaolong Liu
This paper develops ePAC, a cancer vaccine using PEG10-based virus-like particles to deliver neoantigens and adjuvants, showing efficacy in preclinical models.
eLife · Jun 20, 2024Peer-reviewedCancer Biology